Patterns of deterioration in senile dementia of the Alzheimer type. 1995

E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
Department of Psychology, University of Western Ontario, London.

OBJECTIVE To determine rates of decline in Alzheimer's disease. METHODS A longitudinal review of patients diagnosed as having dementia during life, tested serially with the Extended Scale for Dementia, and confirmed by autopsy as having Alzheimer's disease. METHODS Twenty-nine dead patients with Alzheimer's disease from the participants in the University of Western Ontario Dementia Study Project, confirmed at autopsy as having Alzheimer's disease. METHODS Analysis of the Extended Scale for Dementia data according to a trilinear model. RESULTS In the middle phase of the trilinear model, there was a mean annual change of 13% (range, 2.5% to 51.7%). CONCLUSIONS It is likely that the common method of averaging a group of different individual scores from the initial and middle phases of observation of Alzheimer's disease collapses together individuals at different stages of the disorder, some of whom are in the initial plateau phase and whose conditions are not declining rapidly. The trilinear model of decline avoids this difficulty and the present study provides postmortem confirmed figures on rate of change.

UI MeSH Term Description Entries
D008297 Male Males
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia

Related Publications

E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
January 1999, Ryoikibetsu shokogun shirizu,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
October 1999, Nihon Ika Daigaku zasshi,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
November 1983, Annals of neurology,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
January 1984, Clinical pharmacy,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
September 1981, Revue medicale de la Suisse romande,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
January 1985, Neuropsychologia,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
December 1983, Psychiatric journal of the University of Ottawa : Revue de psychiatrie de l'Universite d'Ottawa,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
April 1988, Annals of neurology,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
June 1992, Acta neurologica Scandinavica,
E Helmes, and H Merskey, and H Fox, and R N Fry, and J V Bowler, and V C Hachinski
December 1992, Journal of clinical epidemiology,
Copied contents to your clipboard!